APLMNasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as APLMW
Apollomics Inc.
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Apr 24, 2026
$22.05+0.95 (+4.49%)
Close on Oct 19, 2026
- Market cap
- –
- P/E (TTM)
- –
- Dividend yield
- –
Dividends
Apollomics has not reported a dividend
No dividend per share appears in Apollomics's annual filings since fiscal 2019.